305 related articles for article (PubMed ID: 16442886)
1. Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?
Hernández AV; Boersma E; Murray GD; Habbema JD; Steyerberg EW
Am Heart J; 2006 Feb; 151(2):257-64. PubMed ID: 16442886
[TBL] [Abstract][Full Text] [Related]
2. Primer: the fallacy of subgroup analysis.
Guillemin F
Nat Clin Pract Rheumatol; 2007 Jul; 3(7):407-13. PubMed ID: 17599075
[TBL] [Abstract][Full Text] [Related]
3. Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials.
Parker AB; Naylor CD
Am Heart J; 2000 Jun; 139(6):952-61. PubMed ID: 10827374
[TBL] [Abstract][Full Text] [Related]
4. Subgroup Analyses in Reporting of Phase III Clinical Trials in Solid Tumors.
Zhang S; Liang F; Li W; Hu X
J Clin Oncol; 2015 May; 33(15):1697-702. PubMed ID: 25897150
[TBL] [Abstract][Full Text] [Related]
5. Assessing quality of reports on randomized clinical trials in nursing journals.
Parent N; Hanley JA
Can J Cardiovasc Nurs; 2009; 19(2):25-39. PubMed ID: 19517902
[TBL] [Abstract][Full Text] [Related]
6. Misuse of baseline comparison tests and subgroup analyses in surgical trials.
Bhandari M; Devereaux PJ; Li P; Mah D; Lim K; Schünemann HJ; Tornetta P
Clin Orthop Relat Res; 2006 Jun; 447():247-51. PubMed ID: 16672904
[TBL] [Abstract][Full Text] [Related]
7. Reporting in randomized clinical trials improved after adoption of the CONSORT statement.
Kane RL; Wang J; Garrard J
J Clin Epidemiol; 2007 Mar; 60(3):241-9. PubMed ID: 17292017
[TBL] [Abstract][Full Text] [Related]
8. Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the consolidated standards of reporting trials (CONSORT).
Smith BA; Lee HJ; Lee JH; Choi M; Jones DE; Bausell RB; Broome ME
Nurs Outlook; 2008; 56(1):31-37. PubMed ID: 18237622
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement.
Ziogas DC; Zintzaras E
Ann Epidemiol; 2009 Jul; 19(7):494-500. PubMed ID: 19523596
[TBL] [Abstract][Full Text] [Related]
10. Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals.
Lai TY; Wong VW; Lam RF; Cheng AC; Lam DS; Leung GM
Ophthalmic Epidemiol; 2007; 14(6):390-8. PubMed ID: 18161613
[TBL] [Abstract][Full Text] [Related]
11. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
[TBL] [Abstract][Full Text] [Related]
12. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.
Brookes ST; Whitely E; Egger M; Smith GD; Mulheran PA; Peters TJ
J Clin Epidemiol; 2004 Mar; 57(3):229-36. PubMed ID: 15066682
[TBL] [Abstract][Full Text] [Related]
13. Empirical evaluation of age groups and age-subgroup analyses in pediatric randomized trials and pediatric meta-analyses.
Contopoulos-Ioannidis DG; Seto I; Hamm MP; Thomson D; Hartling L; Ioannidis JP; Curtis S; Constantin E; Batmanabane G; Klassen T; Williams K
Pediatrics; 2012 Jun; 129 Suppl 3():S161-84. PubMed ID: 22661763
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of underpowered randomized clinical trials in rheumatology.
Keen HI; Pile K; Hill CL
J Rheumatol; 2005 Nov; 32(11):2083-8. PubMed ID: 16265683
[TBL] [Abstract][Full Text] [Related]
15. Sex and gender subgroup analyses of randomized trials.
Aulakh AK; Anand SS
Womens Health Issues; 2007; 17(6):342-50. PubMed ID: 17936640
[TBL] [Abstract][Full Text] [Related]
16. Subgroup analysis in therapeutic trials.
Carneiro AV
Rev Port Cardiol; 2002 Mar; 21(3):339-46. PubMed ID: 12017805
[TBL] [Abstract][Full Text] [Related]
17. Sample size calculations in surgery: are they done correctly?
Maggard MA; O'Connell JB; Liu JH; Etzioni DA; Ko CY
Surgery; 2003 Aug; 134(2):275-9. PubMed ID: 12947329
[TBL] [Abstract][Full Text] [Related]
18. Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005.
Conen D; Torres J; Ridker PM
Circulation; 2008 Sep; 118(13):1321-7. PubMed ID: 18779441
[TBL] [Abstract][Full Text] [Related]
19. A new and rapid scoring system to assess the scientific evidence from clinical trials.
Silber S
J Interv Cardiol; 2006 Dec; 19(6):485-92. PubMed ID: 17107362
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.
Pogue J; Walter SD; Yusuf S
Clin Trials; 2009 Jun; 6(3):239-51. PubMed ID: 19528133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
